Tenaya Therapeutics, Inc.
TNYA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001858848
In the last 90 days, Tenaya Therapeutics, Inc. insiders filed 0 open-market purchases and 2 sales; 101 institutions reported holding it in 13F filings for Q2 2026, worth $39.7M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Tenaya Therapeutics, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 103
- +6 vs. Q4 2025
- Shares held
- 54.3M
- −5.74M (−9.6%) vs. Q4 2025
- Total value
- $37.5M
- −$5.20M (−12.2%) vs. Q4 2025
- New holders
- 26
- 33 more added
- Sold out
- 20
- 17 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TNYA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 101 | $39.7M |
| Q1 2026 | 103 | $37.5M |
| Q4 2025 | 98 | $48.8M |
| Q3 2025 | 91 | $55.6M |
| Q2 2025 | 89 | $19.3M |
| Q1 2025 | 107 | $27.7M |
| Q4 2024 | 88 | $62.8M |
| Q3 2024 | 95 | $111.2M |
| Q2 2024 | 96 | $177.0M |
| Q1 2024 | 90 | $292.9M |
| Q4 2023 | 74 | $151.4M |
| Q3 2023 | 77 | $126.8M |
| Q2 2023 | 79 | $279.7M |
| Q1 2023 | 65 | $128.3M |
| Q4 2022 | 68 | $94.7M |
| Q3 2022 | 73 | $102.2M |
| Q2 2022 | 50 | $208.6M |
| Q1 2022 | 50 | $439.9M |
| Q4 2021 | 47 | $667.6M |
| Q3 2021 | 47 | $693.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Tenaya Therapeutics, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Empery Asset Management, LP | 4,286,933 | $2.97M | 3.58% | −1,127,168−20.8% | Reduced |
| Millennium Management LLC | 5,456,666 | $3.78M | 0.00% | +840,920+18.2% | Added |
| Vanguard Capital Management LLC | 8,482,288 | $5.87M | 0.00% | +8,482,288 | New |
| The Column Group LLC | 0 | $0 | 0.00% | −9,400,290−100.0% | Sold out |
| Anson Funds Management LP | 0 | $0 | 0.00% | −4,152,966−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −4,000,000−100.0% | Sold out |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −1,500,000−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −394,500−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −352,001−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −178,764−100.0% | Sold out |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −87,600−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −75,927−100.0% | Sold out |
| Deeter Investments LLP | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −58,235−100.0% | Sold out |
| Atticus Wealth Management, LLC | 0 | $0 | 0.00% | −43,237−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −38,475−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −32,725−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −28,748−100.0% | Sold out |
| Kestra Private Wealth Services, LLC | 0 | $0 | 0.00% | −22,000−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −16,200−100.0% | Sold out |
| X-Square Capital, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Torren Management, LLC | 0 | $0 | 0.00% | −3,673−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |